Market Currents
Jazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety...
-
Tuesday, October 18, 2011, 9:49 AM ETJazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety violations, including "failure to develop adequate written procedures for the surveillance, receipt, evaluation, and reporting of postmarketing adverse drug experiences to FDA."
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
